請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/78006
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 吳信志 | |
dc.contributor.author | Ting-Kuan Lin | en |
dc.contributor.author | 林庭寬 | zh_TW |
dc.date.accessioned | 2021-07-11T14:39:29Z | - |
dc.date.available | 2022-02-21 | |
dc.date.copyright | 2017-02-21 | |
dc.date.issued | 2017 | |
dc.date.submitted | 2017-02-13 | |
dc.identifier.citation | Aerbajinai, W., T. Tsuchiya, A. Kimura, Y. Yasukochi, and F. Numano. 1996. HLA class II DNA typing in Buerger's disease. Int. J. Cardiol. 54 Suppl.: S197-202.
Anders, C., O. Niewoehner, A. Duerst, and M. Jinek. 2014. Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature 513: 569-573. Anderson, E. M. et al. 2015. Systematic analysis of CRISPR-Cas9 mismatch tolerance reveals low levels of off-target activity. J. Biotechnol. 211: 56-65. Barrangou, R. et al. 2007. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315: 1709-1712. Bolukbasi, M. F., A. Gupta, and S. A. Wolfe. 2016. Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery. Nat. Methods 13: 41-50. Chandrasegaran, S., and D. Carroll. 2016. Origins of Programmable Nucleases for Genome Engineering. Journal of molecular biology 428: 963-989. Chen, B. et al. 2013. Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell 155: 1479-1491. Chen, Y. et al. 2015. Functional disruption of the dystrophin gene in rhesus monkey using CRISPR/Cas9. Hum. Mol. Genet. 24: 3764-3774. Christian, M. et al. 2010. Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 186: 757-761. Daer, R., J. P. Cutts, D. A. Brafman, and K. A. Haynes. 2016. The impact of chromatin dynamics on Cas9-mediated genome editing in human cells. ACS. Synth. Biol. Dang, Y. et al. 2015. Optimizing sgRNA structure to improve CRISPR-Cas9 knockout efficiency. Genome. Biol. 16: 280. Doench, J. G. et al. 2014. Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat. Biotechnol. 32: 1262-1267. Esvelt, K. M. et al. 2013. Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat. Methods 10: 1116-1121. Feng, Z. et al. 2014. Multigeneration analysis reveals the inheritance, specificity, and patterns of CRISPR/Cas-induced gene modifications in Arabidopsis. Proc. Natl. Acad. Sci. U. S. A. 111: 4632-4637. Fonfara, I. et al. 2014. Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems. Nucleic. Acids Res. 42: 2577-2590. Fu, Y. et al. 2013. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat. Biotechnol. 31: 822-826. Fu, Y., J. D. Sander, D. Reyon, V. M. Cascio, and J. K. Joung. 2014. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat. Biotechnol. 32: 279-284. Gasiunas, G., R. Barrangou, P. Horvath, and V. Siksnys. 2012. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl. Acad. Sci. U. S. A. 109: E2579-2586. Hashimoto, M., and T. Takemoto. 2015. Electroporation enables the efficient mRNA delivery into the mouse zygotes and facilitates CRISPR/Cas9-based genome editing. Sci. Rep. 5: 11315. Horii, T. et al. 2014. Validation of microinjection methods for generating knockout mice by CRISPR/Cas-mediated genome engineering. Sci. Rep. 4: 4513. Horlbeck, M. A. et al. 2016. Nucleosomes impede Cas9 access to DNA in vivo and in vitro. Elife 5. Hwang, W. Y. et al. 2013. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat. Biotechnol. 31: 227-229. Jiang, W., D. Bikard, D. Cox, F. Zhang, and L. A. Marraffini. 2013. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat. Biotechnol. 31: 233-239. Jinek, M. et al. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337: 816-821. Jinek, M. et al. 2014. Structures of Cas9 endonucleases reveal RNA-mediated conformational activation. Science 343: 1247997. Kim, H., and J. S. Kim. 2014. A guide to genome engineering with programmable nucleases. Nat. Rev. Genet. 15: 321-334. Kim, J. S. et al. 2005. Independent and sequential recruitment of NHEJ and HR factors to DNA damage sites in mammalian cells. The Journal of cell biology 170: 341-347. Kim, Y. G., J. Cha, and S. Chandrasegaran. 1996. Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc. Natl. Acad. Sci. U. S. A. 93: 1156-1160. Kleinstiver, B. P. et al. 2016. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529: 490-495. Kohn, D. B., M. H. Porteus, and A. M. Scharenberg. 2016. Ethical and regulatory aspects of genome editing. Blood 127: 2553-2560. Li, D. et al. 2013. Heritable gene targeting in the mouse and rat using a CRISPR-Cas system. Nat. Biotechnol. 31: 681-683. Li, X. Q., and D. Du. 2014. Variation, evolution, and correlation analysis of C+G content and genome or chromosome size in different kingdoms and phyla. PLoS One 9: e88339. Liang, G., H. Zhang, D. Lou, and D. Yu. 2016. Selection of highly efficient sgRNAs for CRISPR/Cas9-based plant genome editing. Sci. Rep. 6: 21451. Liang, P. et al. 2015. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein Cell 6: 363-372. Lin, Y. et al. 2014. CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences. Nucleic. Acids Res. 42: 7473-7485. Liu, X. et al. 2016. Sequence features associated with the cleavage efficiency of CRISPR/Cas9 system. Sci. Rep. 6: 19675. Ma, X. et al. 2015. A Robust CRISPR/Cas9 System for Convenient, High-Efficiency Multiplex Genome Editing in Monocot and Dicot Plants. Mol. Plant 8: 1274-1284. Malina, A. et al. 2015. PAM multiplicity marks genomic target sites as inhibitory to CRISPR-Cas9 editing. Nat. Commun. 6: 10124. Mashiko, D. et al. 2013. Generation of mutant mice by pronuclear injection of circular plasmid expressing Cas9 and single guided RNA. Sci. Rep. 3: 3355. Moreno-Mateos, M. A. et al. 2015. CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo. Nat. Methods 12: 982-988. Nishimasu, H. et al. 2014. Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell 156: 935-949. Niu, Y. et al. 2014. Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos. Cell 156: 836-843. Orr-Weaver, T. L., J. W. Szostak, and R. J. Rothstein. 1981. Yeast transformation: a model system for the study of recombination. Proc. Natl. Acad. Sci. U. S. A. 78: 6354-6358. Palmbos, P. L., D. Wu, J. M. Daley, and T. E. Wilson. 2008. Recruitment of Saccharomyces cerevisiae Dnl4-Lif1 complex to a double-strand break requires interactions with Yku80 and the Xrs2 FHA domain. Genetics 180: 1809-1819. Qin, W. et al. 2015. Efficient CRISPR/Cas9-Mediated Genome Editing in Mice by Zygote Electroporation of Nuclease. Genetics 200: 423-430. Ran, F. A. et al. 2015. In vivo genome editing using Staphylococcus aureus Cas9. Nature 520: 186-191. Ren, C. et al. 2016. CRISPR/Cas9-mediated efficient targeted mutagenesis in Chardonnay (Vitis vinifera L.). Sci. Rep. 6: 32289. Ren, X. et al. 2014. Enhanced specificity and efficiency of the CRISPR/Cas9 system with optimized sgRNA parameters in Drosophila. Cell Rep. 9: 1151-1162. Scherer, S., and R. W. Davis. 1979. Replacement of chromosome segments with altered DNA sequences constructed in vitro. Proc. Natl. Acad. Sci. U. S. A. 76: 4951-4955. Shan, Q. et al. 2013. Targeted genome modification of crop plants using a CRISPR-Cas system. Nat. Biotechnol. 31: 686-688. Singh, P., J. C. Schimenti, and E. Bolcun-Filas. 2015. A mouse geneticist's practical guide to CRISPR applications. Genetics 199: 1-15. Slaymaker, I. M. et al. 2016. Rationally engineered Cas9 nucleases with improved specificity. Science 351: 84-88. Sternberg, S. H., S. Redding, M. Jinek, E. C. Greene, and J. A. Doudna. 2014. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature 507: 62-67. Sung, Y. H. et al. 2014. Highly efficient gene knockout in mice and zebrafish with RNA-guided endonucleases. Genome. Res. 24: 125-131. Wan, H. et al. 2015. One-step generation of p53 gene biallelic mutant Cynomolgus monkey via the CRISPR/Cas system. Cell Res. 25: 258-261. Wang, H. et al. 2013. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153: 910-918. Wang, T., J. J. Wei, D. M. Sabatini, and E. S. Lander. 2014. Genetic screens in human cells using the CRISPR-Cas9 system. Science 343: 80-84. Wang, W. et al. 2016. Delivery of Cas9 Protein into Mouse Zygotes through a Series of Electroporation Dramatically Increases the Efficiency of Model Creation. J. Genet. Genomics 43: 319-327. Wilson, T. E., U. Grawunder, and M. R. Lieber. 1997. Yeast DNA ligase IV mediates non-homologous DNA end joining. Nature 388: 495-498. Wu, X., A. J. Kriz, and P. A. Sharp. 2014a. Target specificity of the CRISPR-Cas9 system. Quantitative biology 2: 59-70. Wu, X. et al. 2014b. Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat. Biotechnol. 32: 670-676. Xu, H. et al. 2015. Sequence determinants of improved CRISPR sgRNA design. Genome Res. 25: 1147-1157. Yang, D. et al. 2014. Effective gene targeting in rabbits using RNA-guided Cas9 nucleases. J. Mol. Cell Biol. 6: 97-99. Yang, H. et al. 2013. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 154: 1370-1379. Yano, K. et al. 2008. Ku recruits XLF to DNA double-strand breaks. EMBO reports 9: 91-96. Yasue, A. et al. 2014. Highly efficient targeted mutagenesis in one-cell mouse embryos mediated by the TALEN and CRISPR/Cas systems. Sci. Rep. 4: 5705. Yen, S. T. et al. 2014. Somatic mosaicism and allele complexity induced by CRISPR/Cas9 RNA injections in mouse zygotes. Dev. Biol. 393: 3-9. Yu, Z. et al. 2013. Highly efficient genome modifications mediated by CRISPR/Cas9 in Drosophila. Genetics 195: 289-291. Zhang, J. P. et al. 2016. Different Effects of sgRNA Length on CRISPR-mediated Gene Knockout Efficiency. Sci. Rep. 6: 28566. Zhang, Y. et al. 2014. Comparison of non-canonical PAMs for CRISPR/Cas9-mediated DNA cleavage in human cells. Sci. Rep. 4: 5405. SnapGene software (from GSL Biotech; available at snapgene.com) | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/78006 | - |
dc.description.abstract | Clustered regularly interspaced short palindromic repeat (CRISPR)-CRISPR associated protein 9 (Cas9)自從2012年由細菌免疫系統發展為基因標靶 (gene targeting) 工具後,因其便利及高效性,迅速取代鋅指蛋白核酸酶 (zinc-finger nuclease, ZFN) 及transcription activator-like effector nuclease (TALEN)。CRISPR-Cas9系統含sgRNA (single guide RNA) 與Cas9兩功能角色,sgRNA為短片段單股RNA,3’端之二級結構可與Cas9結合,以5’端之20個鹼基辨識DNA序列,最後藉Cas9之核酸酶活性對目標DNA截切造成雙股斷裂 (double strand break)。先前研究發現不同目標DNA序列對CRISPR-Cas9作用效率造成大幅度波動,介於0-100%,如何維持高作用效率為目前待解決之問題。GC含量為DNA序列基本特徵,研究顯示其亦為影響CRISPR-Cas9作用效率之重要因子,當目標DNA序列之GC含量低於30%或高於80%會抑制其作用效率,且發現高於50%時有較高效率,有潛力可作為挑選目標序列之依據。本研究根據CRISPR-Cas9作用機制對sgRNA序列辨識區進行分段設計,比較3’端 (第1-6個鹼基)、中間區段 (第7-12個鹼基) 及5’端 (第13-20個鹼基),深入探討GC含量對作用效率之影響。試驗首先針對EGFP DNA序列設計22條sgRNA,以EGFP轉基因小鼠之胚胎纖維母細胞 (mouse embryonic fibroblast, MEF) 進行體外試驗,將表現質體以脂質體轉染 (liposome transfection, lipofection) 轉入MEF,測試不同sgRNA對EGFP剔除作用效率。此後根據細胞試驗結果,挑選4條sgRNA以小鼠胚進行體內試驗,將體外轉錄 (in vitro transcription, IVT) 製備之RNA對小鼠胚細胞質進行顯微注射 (microinjection),此後將胚培養至囊胚或移入代理孕母,計算囊胚及出生小鼠EGFP剔除效率,並與MEF之體外試驗結果比較。試驗結果顯示sgRNA GC含量提高時EGFP剔除作用效率有下降趨勢,GC含量50%以下作用效率較高,此外降低sgRNA中間區段GC含量對於作用效率提高效果顯著高於3’端及5’端。根據以上結果,未來可於GC含量較低之DNA序列設計sgRNA,以提高CRISPR-Cas9作用效率。然而,本試驗結果顯示GC含量50%以下呈現較高效率,與先前研究不符,由於目前尚未完全瞭解其分子機制,欲釐清需更深入之探討。 | zh_TW |
dc.description.abstract | The robust gene editing tool, clustered regularly interspaced short palindromic repeat (CRISPR)-CRISPR associated protein 9 (Cas9), was derived from bacteria immune system in 2012. Because of its convenience and high efficiency, it had quickly replaced current gene targeting tools, zinc-finger nuclease (ZFN) and transcription activator-like effector nuclease (TALEN). CRISPR-Cas9 system contains two functional members, one is a short single strand RNA called single guide RNA (sgRNA) and another is the Cas9 nuclease. Cas9 will combine with sgRNA via binding the secondary structure at 3’ end of sgRNA, makes Cas9 transform into an active conformation. And then uses a 20 nucleotide sequence recognized region at 3’ end of sgRNA to recognize target DNA sequence, induces a DNA double strand breaking. The previous study found CRISPR-Cas9 efficiency had a great variation from 0% to 100% while targeting different target sequence. Made it necessary to figure out how to find a high-efficiency target sequence. GC content is one of the important DNA characters. Recent reports recommend that CRISPR-Cas9 target site should be 30-80% of GC content to avoid very low efficiency. Besides, GC content higher than 50% is more efficient. These both implied GC content might be a useful parameter to select target DNA region. Therefore, this study focused on how GC content influences CRISPR-Cas9 efficiency. Segmentally designed the sgRNA recognition region and compared the influence of the GC content at 3’ end (1-6 nucleotide), mid region (7-12 nucleotide) and 5’ end (13-20 nucleotide). In this study, we took advantage of the EGFP transgenic mice as the cell and embryo origin and compared the efficiency of 22 sgRNAs targeting EGFP. In the first part, we isolated mouse embryonic fibroblast (MEF) for cell-based in vitro experiment. Transfected the CRISPR-Cas9 expression plasmid into MEF by liposome (lipofection), and compared the EGFP knockout efficiency of 22 sgRNAs. And then, selected 4 sgRNAs to the second part embryo-based in vivo experiment according to cell-based data. Used microinjection method to inject CRISPR RNA into the mouse embryo. Cultured the injected embryo to blastocyst or transfer the embryo to the surrogate female mouse. Calculated EGFP knockout efficiency in blastocyst or pup, and compared the result with cell-based data. The results showed that increasing GC content had a negative effect on EGFP knockout efficiency. sgRNA with GC content lower than 50% had the better EGFP knockout rate. And decreasing GC content at the mid region of sgRNA could enhance EGFP knockout efficiency more than at 3’ or 5’ end. To sum up, in the future, we can design sgRNAthat targeting the DNA sequence with lower GC content to increase the CRISPR-Cas9 efficiency. However, the result that sgRNA with GC content lower than 50% is more efficient is inconsistent. It will need further research to investigate. | en |
dc.description.provenance | Made available in DSpace on 2021-07-11T14:39:29Z (GMT). No. of bitstreams: 1 ntu-106-R03626013-1.pdf: 4544308 bytes, checksum: 7cbffad6412eb96724010fc07175b577 (MD5) Previous issue date: 2017 | en |
dc.description.tableofcontents | 致謝 I
摘要 II ABSTRACT III 目次 V 圖次 VIII 表次 IX 第一章 緒言 1 第二章 文獻探討 2 第一節 基因標靶技術 2 1-1 基因標靶技術之發展 2 1-2 ZFN、TALEN及CRISPR-Cas9 3 1-3 CRISPR-Cas9系統與其餘兩者之優缺點比較 4 第二節 CRISPR-Cas9基因編輯作用原理 6 2-1 CRISPR-Cas9結合與截切目標DNA 6 2-2 Cas9核酸酶 6 2-3 sgRNA 7 2-4 DNA雙股斷裂修復 7 2-5 CRISPR-Cas9專一性 10 第三節 影響CRISPR-Cas9作用效率之因子 10 3-1 與DNA結合前:sgRNA序列 12 3-2 與DNA結合前:sgRNA長度 12 3-3 與DNA結合前:Cas9蛋白質種類 12 3-4 與DNA結合時:PAM 種類 13 3-5 與DNA結合時:DNA可接近性 (Accessibility) 13 3-6 與DNA結合後:序列特性-鹼基偏好 13 3-7 與DNA結合後:序列特性-GC鹼基比例 14 3-8 總結CRISPR-Cas9作用效率 14 第四節 GC含量與CRISPR-Cas9 14 第五節 CRISPR-Cas9顯微注射 15 第三章 試驗一:細胞體外試驗 19 第一節 試驗背景 19 第二節 試驗流程 19 第三節 材料方法 20 3-1 CRISPR-Cas9表現載體構築 (圖5) 20 3-2 小鼠胚胎纖維母細胞製備 23 3-3 MEF轉染CRISPR-Cas9表現載體 24 3-4 sgRNA作用效率計算 24 第四節 試驗結果 25 4-1 EGFP基因sgRNA之設計及CRISPR-Cas9表現質體轉染 25 4-2 分析總GC含量及分段GC含量對sgRNA作用效率之影響 30 4-3 其餘影響因子 34 第五節 試驗結論 36 第四章 試驗二:小鼠胚體內試驗 37 第一節 試驗背景 37 第二節 試驗流程 37 第三節 材料方法 38 3-1 試驗用小鼠 38 3-2 sgRNA及Cas9 mRNA IVT質體構築 38 3-3 sgRNA及Cas9 mRNA IVT 41 3-4 RNA細胞質顯微注射 41 3-5 囊胚細胞計數 43 3-6 偵測Cas9蛋白質表現量 43 3-7 sgRNA作用效率計算 44 第四節 試驗結果 45 4-1 RNA細胞質注射對小鼠胚之毒性測試 45 4-2 於小鼠胚對EGFP基因剔除效率 47 第五節 試驗結論 52 第五章 討論 53 第一節 探討GC含量對於CRISPR-Cas9作用效率之影響 53 第二節 E-92於兩部分試驗不相符之原因 54 第三節 Cas9結構與作用效率之關係 54 第六章 結論 57 參考文獻 58 附錄 63 一、藥品及試劑列表 63 二、配方列表 64 三、儀器列表 66 四、寡核甘酸列表 66 五、質體構築寡核甘酸列表 67 六、小鼠胚顯微操作統計表 69 | |
dc.language.iso | zh-TW | |
dc.title | 探討GC鹼基含量對CRISPR/Cas9基因標靶技術作用效率之影響 | zh_TW |
dc.title | The Effect of GC Content in Efficiency of CRISPR/Cas9 Gene Targeting Technology | en |
dc.type | Thesis | |
dc.date.schoolyear | 105-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 宋麗英,鄭登貴 | |
dc.subject.keyword | CRISPR-Cas9,基因剔除效率,GC含量,分段設計, | zh_TW |
dc.subject.keyword | CRISPR-Cas9,knockout efficiency,GC content,segment design, | en |
dc.relation.page | 69 | |
dc.identifier.doi | 10.6342/NTU201700555 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2017-02-14 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 動物科學技術學研究所 | zh_TW |
顯示於系所單位: | 動物科學技術學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-106-R03626013-1.pdf 目前未授權公開取用 | 4.44 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。